Skip to main content
. 2021 Jan-Feb;66(1):67–73. doi: 10.4103/ijd.IJD_206_20

Table 5.

Changes in IL-10 between treatment arms

IL-10 PPD group (n=9) Mw group (n=11) MMR group (n=12) P (between groups)
Baseline 35.42±37.58 56.07±47.65 53.42±30.33 0.222
19 (7.9, 63.5) 37 (26.25, 66.5) 47.5 (28, 78)
End of treatment 19.27±25.25 36.51±32.61 32.05±32.56 0.396
5 (0.88, 29.75) 21 (8.25, 68.25) 21.05 (2.5, 63.5)
P (within groups) 0.027 0.123 0.001

P-value for between groups by Kruskal–Wallis ANOVA. P-value for within groups by Wilcoxon test